Brian L. Abbott
Impact in
- Hematology top 10%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research
Papers in
- Oncology 10
- Drug Transport and Resistance Mechanisms 5
-
- Lymphoma Diagnosis and Treatment 6
- Genetic factors in colorectal cancer 3
- Co-authors
- Michael Andreeff (1 shared paper)Brian P. Sorrentino (1 shared paper)Frank C. Marini (1 shared paper)Cindy Ippoliti (2 shared papers)RE Champlin (2 shared papers)J Bruton (2 shared papers)Xiaolin Sun (1 shared paper)Weidong Yu (1 shared paper)
- Journals
- Journal of Clinical Oncology (8 papers)Bone Marrow Transplantation (2 papers)Hematological Oncology (2 papers)Therapeutic Innovation & Regulatory Science (1 paper)Blood (1 paper)
- Partner nations
- United StatesPakistan
In The Last Decade
Brian L. Abbott
22 papers receiving 399 citations
Peers
Comparison fields: 5 of 62
- Hematology 94
- Genetics 79
- Oncology 180
- Pathology and Forensic Medicine 44
- Pediatrics, Perinatology and Child Health 42
Countries citing papers authored by Brian L. Abbott
This map shows the geographic impact of Brian L. Abbott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian L. Abbott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian L. Abbott more than expected).
Fields of papers citing papers by Brian L. Abbott
This network shows the impact of papers produced by Brian L. Abbott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian L. Abbott. The network helps show where Brian L. Abbott may publish in the future.
Co-authors
The 25 scholars most cited alongside Brian L. Abbott, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 99 | |
| 2 | 2003 | 61 | |
| 3 | 2006 | 49 | |
| 4 | 2007 | 40 | |
| 5 | ABCG2 (BCRP): a cytoprotectant in normal and malignant stem cells. | 2006 | 34 |
| 6 | 2004 | 26 | |
| 7 | 1999 | 24 | |
| 8 | 2000 | 17 | |
| 9 | 2012 | 12 | |
| 10 | 2014 | 10 | |
| 11 | 2015 | 6 | |
| 12 | 2005 | 5 | |
| 13 | Advances in the diagnosis and treatment of chronic lymphocytic leukemia. | 2004 | 5 |
| 14 | 2006 | 4 | |
| 15 | 2016 | 3 | |
| 16 | 2015 | 3 | |
| 17 | 2013 | 2 | |
| 18 | 2013 | 2 | |
| 19 | 2006 | 2 | |
| 20 | 2025 | 1 |
About Brian L. Abbott
Brian L. Abbott is a scholar working on Oncology, Pathology and Forensic Medicine, Genetics, Cancer Research and Pulmonary and Respiratory Medicine, having authored 26 papers that have together received 407 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (6 papers), Chronic Lymphocytic Leukemia Research (6 papers), Cancer Genomics and Diagnostics (5 papers), Drug Transport and Resistance Mechanisms (5 papers), BRCA gene mutations in cancer (3 papers), Immunodeficiency and Autoimmune Disorders (3 papers), Lung Cancer Treatments and Mutations (3 papers) and Genetic factors in colorectal cancer (3 papers). The work is most often cited by research in Hematology (94 citations), Genetics (79 citations), Oncology (180 citations), Pathology and Forensic Medicine (44 citations) and Pediatrics, Perinatology and Child Health (42 citations). Brian L. Abbott has collaborated with scholars based in United States and Pakistan. Frequent co-authors include Michael Andreeff, Brian P. Sorrentino, Frank C. Marini, Cindy Ippoliti, RE Champlin, J Bruton, Xiaolin Sun, Weidong Yu, Christopher Hogan and Zonghan Dai. Their work appears in journals such as Journal of Clinical Oncology, Bone Marrow Transplantation, Hematological Oncology, Therapeutic Innovation & Regulatory Science and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.